artaira
Home / Compression Therapy Products / ARTAIRA Arterial Compression Device

Easy, Effective, At-Home Treatment for Individuals with Symptoms of Peripheral Arterial Disease (PAD)

The new FDA-cleared ARTAIRA® Arterial Compression device delivers rapid, high-pressure compression to vastly increase blood flow and circulation to the lower legs, feet, and toes.

Continue Reading

ARTAIRA OVERVIEW

Trusted Therapy. Proven Science. Real Relief.

Experience how trusted therapy meets modern innovation with the ARTAIRA Arterial Compression Device — an FDA-cleared intermittent pneumatic compression (IPC) system engineered to increase arterial blood flow in patients with symptoms of Peripheral Arterial Disease (PAD) and Chronic Limb-Threatening Ischemia (CLTI). Through rapid, high-pressure inflation and deflation cycles, ARTAIRA enhances circulation, supports wound healing, reduces rest pain, and helps patients walk farther with greater comfort, improving quality of life and potentially reducing the need for amputation.


A New, User-Friendly, At-Home Therapy Option

How ARTAIRA Works

The device delivers 120 mmHg rapid, sequential compression to the foot, ankle, and calf in a repeating 20-second cycle:

  • Foot/Ankle inflation (3 seconds)
  • Calf inflation (3 seconds)
  • Deflation/Rest (17 seconds)
  • These repetitive inflation/deflation sequences mimic fast walking, without pain. Venous blood is emptied in the small vessels, allowing arterial blood to more easily flow to the feet and toes. This type of compression therapy could provide long-term blood flow enhancements – and even heal ulcers and potentially prevent amputation.

Extend Care Beyond the Clinic

A Non-Invasive Therapy for Complex Arterial Disease

ARTAIRA is designed to help extend arterial therapy beyond the office, offering a non-invasive option for patients with challenging circulation conditions. Intermittent Pneumatic Compression (IPC) has been shown to support patients with arterial disorders, particularly when traditional revascularization options are limited. Clinical guidance, including a 2024 Clinical Practice Guideline published in the Journal of the American College of Cardiology, recognizes arterial IPC as a potential therapy to help augment wound healing and relieve ischemic rest pain in patients with chronic limb-threatening ischemia.

Built on proven treatment principles, ARTAIRA delivers rapid, high-pressure compression—an approach shown in multiple clinical studies to improve circulation in patients with arterial insufficiency, diabetic foot complications, and other manifestations of PAD. By leveraging these established mechanisms, ARTAIRA helps promote blood flow to the lower extremities, supporting tissue health and patient comfort outside the clinical setting.

ARTAIRA Resource

ARTAIRA Arterial Compression Device

A comprehensive look at ARTAIRA arterial compression therapy — including device features, expected patient benefits, and how consistent use supports circulation at home or on the go.

ARTAIRA KEY Features AND BENEFITS

Powerful Compression Technology for Arterial Insufficiency Treatment

Durable Garments

Durable garments are easy to put on and take off. One size fits all. 

User-Friendly

Therapy started/stopped with a single press of a button.

Color LCD Screen

User can clearly see a countdown cycle showing when to expect leg compressions, as well as the time remaining in the therapy session.

Pause Function

PAUSE/RESUME button allows therapy to be ceased temporarily if needed, and therapy can be continued in the middle of a session.

Usage Tracking

Built-in timer records usage time to measure/ensure patient compliance.

Portable

Compact and portable design for easy transportation.


Ideal Patients

Who Should Use ARTAIRA

Patients with
These Symptoms

  • Chronic limb-threatening ischemia (CLTI/CLI)
  • Intermittent claudication (walking pain) and rest pain
  • Diabetic and arterial foot ulcers
  • Slow-healing wounds
  • Ischemic neuritis
  • Gangrene
  • Poor runoff

When Surgery is
Not an Option

  • When surgery or intervention is not possible, contraindicated, or failed previously
  • As a last resort to avoid amputation

Before or After Surgery
or Intervention

  • Patients waiting for surgery, such as vascular intervention
  • Potential use as adjunctive therapy when increased blood flow is desired after surgery (with Vascular Specialist oversight)

HOW TO USE

How to Apply the ARTAIRA Garment

YouTube player

Step-by-Step Setup for Arterial Compression Therapy

This short video walks you through how to properly apply and secure your ARTAIRA Arterial Compression Garment. You’ll learn how to set up the device, position the garment for a comfortable, effective fit, and start therapy with confidence to support healthy blood flow to the lower legs, feet, and toes.

More Information & Answers

Frequently Asked Questions

We answer your most common questions about ARTAIRA and how it can help manage PAD and related conditions.

How does ARTAIRA work?

ARTAIRA uses intermittent pneumatic compression (IPC) to sequentially compress the foot and calf three times per minute at high pressure. These compression sequences mimic fast walking and improves blood flow to the feet, ankles, and toes, helping to reduce pain, heal ulcers, and potentially prevent amputation.

Who can benefit from ARTAIRA?

Patients with symptoms of Peripheral Arterial Disease (PAD), including diabetic foot ulcers and critical limb ischemia, can benefit from ARTAIRA’s non-invasive therapy. Physicians such as vascular specialists and podiatrists recommend arterial pumps for their patients – including those that are not candidates for surgery.

How can I get an ARTAIRA device?

The ARTAIRA device is prescription-only and available through Durable Medical Equipment (DME) suppliers. If you are a physician interested in acquiring a device for your patient, we can connect you with a DME in our wide network. If you are a podiatrist who owns a DME, you may be able to purchase the device and resell it to your patients. If you are a patient looking to obtain a device, we can advise on the documentation needed from your physician and put you in contact with a DME in our network. Contact us to learn how you can get an ARTAIRA device.

Is ARTAIRA clinically validated?

Intermittent pneumatic compression (IPC) pumps have been proven to help patients suffering from poor blood flow to the lower extremities. Various studies have shown that IPC pumps focused on promoting arterial blood flow allow patients to walk longer distances without pain and experience various other health benefits. The ARTAIRA device is built upon previous technology, and data is being collected from patients currently using the device. 

How easy is ARTAIRA to use?

ARTAIRA is designed for simplicity. It features one-button operation, a clear LCD screen, and comfortable, easy-to-apply garments. Its user-friendly design ensures that patients and caregivers can use it effectively at home.

Are there any contraindications for using ARTAIRA?

Yes, ARTAIRA should not be used by individuals with conditions such as deep vein thrombosis (DVT), pulmonary embolism, congestive heart failure (CHF), or active infections in the treatment area. Always consult a physician before use.

NEED MORE INFORMATION? Contact Us Today.

Are you a patient with questions about your device? A DME supplier interested in learning about compression devices? A clinician seeking product information? Please contact us to speak with an AIROS Medical representative.